Results

Total Results: 1,541 records

Showing results for "months".

81. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd_executive.pdf
    September 01, 2011 - more effective than ranitidine 150 mg taken twice daily for the prevention of symptom relapse at 6 months … The durations of followup ranged from 1 to 6 months. … ), pantoprazole (20 to 40 mg), or rabeprazole (10 to 20 mg) over a period ranging from 4 weeks to 6 months … The time periods of followup ranged from 1 to 12 months. … Followup ranged from 1 to 12 months.

82. Evidence-based Practice Center Systematic Review Protocol - Management of Infantile Epilepsies (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-252-infantile-epilepsies-disposition-comments.pdf
    October 25, 2022 - the authors’ responses to the comments are posted for public viewing on the website approximately 3 months … rather than switching between 36 months and 3 years, updating language describing seizure types, and … Personally, I care for an infant who was diagnosed with epilepsy at 9 months, and presently at 21 months … Epilepsy surgery in infants up to 3 months of age: Safety, feasibility, and outcomes: A multicenter, … There are risks in those < 3 months and 5 kg so surgeons are reluctant to operate on this group.

83. Cancer-Drugs-Utilization Research (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization_research.pdf
    January 01, 2011 - Fewer than 50 percent of beneficiaries with bevacizumab orders had a cancer diagnosis in the prior 6 months … cancer subchapter 2 Findings Use of Monoclonal Antibodies by neoplasm iCd-9 subchapter In the 6 months … The biologics included: gemtuzumab (97 percent of beneficiaries had such a diagnosis in the 6 months … (%) of rituximab users with a malignancy of lymphatic and hematopoietic tissue diagnosis in the 6 months … percent of benefi- ciaries with an order for bevacizumab did not have a cancer diagnosis in the 6 months

84. Digestible Carbohydrate Intake and Maternal-Infant Outcomes: A Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/carbohydrate-intake-protocol.pdf
    April 08, 2024 - the scope of this review is limited to outcomes during pregnancy, at birth, and up to the first 24 months … adulthood.4,5 Current dietary guidelines for pregnant individuals and infants birth up to 24 months … Lacking sufficient evidence to determine a DRI for carbohydrate for infants 0–12 months of age, an adequate … For infants 0 to 6 months of age the AI for carbohydrate is 60 g/d, while for infants 6 to 12 months … intake to important health outcomes for pregnant people and their offspring from birth through 24 months

85. Attention Deficit Hyperactivity Disorder: Executive Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/adhd_executive.pdf
    October 01, 2011 - However, no long­term study (lasting 12 months or more) of PBT alone included untreated comparison … groups, and attrition was high, from 24 percent at 18 months to 54 percent at 3 to 6 years, limiting … Three of these five studies followed children for 12 months, while the other two assessed children … psychosocial intervention,75 and another examined relapse in children receiving ATX for 12 months. … ATX is effective for ADHD symptoms and well tolerated over 12 months.

86. Heart-Failure-Transition-Care Clinician (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/heart-failure-transition-care_clinician.pdf
    October 01, 2015 - all-cause readmissions (high strength of evidence [SOE]*) and mortality (moderate SOE) over 3 to 6 months … telephone support reduced HF-specific readmissions (high SOE) and mortality (moderate SOE) over 3 to 6 months … Evidence for Transitional Care Interventions Versus Usual Care for HF Intervention Outcome at 3–6 Months … of life: HF-specific quality of life was greater for home-visiting programs than usual care over 3 months … (low SOE) but not at 6 months (low SOE). �� Emergency room (ER) visits: Evidence was insufficient

87. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_executive-2007.pdf
    January 01, 2007 - compared to renal artery angioplasty with stent placement on long-term clinical outcomes (at least 6 months … compared angioplasty (without stent placement) with medical therapy and followed patients for at least 6 months … immediate angioplasty and either medical therapy alone or medical therapy followed by angioplasty at 3 months … found either no significant differences or inconsistent differences in QoL at 3 and 12 months.

88. Evaluation of Dietary Protein Intake Requirements (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-protein-intake-protocol-amendment.pdf
    November 28, 2023 - Indicator AA oxidation method ● Mean protein intake of infants fed principally human milk (0-6 months … ) ● Mean protein content of human milk (0-6 months) ● Body composition (lean mass) ● Linear growth … ) ● Mean protein content of human milk (0-6 months) Timing KQ1 & 2 ● All duration and follow up … ) ● Mean protein content of human milk (0-6 months) ● Body composition (lean mass) ● Linear … )” and “mean AA intake of infants fed principally human milk (0-6 months)” was excluded in order

89. Arthritis and Nontraumatic Joint Disease (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/01_arthritis_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - Physician global assessment improved 51% and 53% from baseline at 6 and 12 months, respectively. … Fifty-foot walk pain improved 26% and 17% from baseline at 6 and 12 months, respectively. … At 3 months, patients taking placebo who were not responding were given tofacitinib. … At 6 months, all placebo-assigned patients were given tofacitinib. … Patients given placebo were given tofacitinib at 3 months.

90. Cer-276-Ocd-Appendix-H (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-276-ocd-appendix-h.xlsx
    January 01, 2023 - 0.48 1.43 0.739 NS Neutral (Nonsignificant) 37669531 Farrell 2020 DWS Griffith U, Queensland AU 6 months … 0.05 0.52 0.924 NS Neutral (Nonsignificant) 37669531 Farrell 2020 DWS Griffith U, Queensland AU 6 months … 2.17 3.36 0.521 NS Neutral (Nonsignificant) 37669531 Farrell 2020 DWS Griffith U, Queensland AU 6 months … 4.33 3.78 0.257 NS Neutral (Nonsignificant) 37669531 Farrell 2020 DWS Griffith U, Queensland AU 6 months … 7.66 5.74 0.187 NS Neutral (Nonsignificant) 37669531 Farrell 2020 DWS Griffith U, Queensland AU 6 months

91. Executive Summary: Breastfeeding and Health Outcomes for Infants and Children (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/breastfeeding-health-outcomes-research-executive-summ.pdf
    March 01, 2025 - with ever breastfeeding and longer durations of any and exclusive breastfeeding, particularly at ≤24 months … of more severe respiratory infections associated with breastfeeding, particularly among infants ≤24 months … of moderate to severe GI infections and breastfeeding at younger ages, particularly in infants ≤6 months … Dental caries Approximate 54% increased risk of dental caries associated with breastfeeding 12 months

92. QR Medica Web Site (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/ebc-challenge-1stplace-qrmedica.pdf
    January 01, 2013 - Recurrent Otitis Media (ROM) is defined as three or more episode in six months, or four or more episodes … in twelve months. … Association of Family Physicians (AAFP) recommend antibiotics for all children under the age of six months … It is recommended to take a “wait and watch” approach for otherwise healthy children ages six months … There is a recommendation for children 2-23 months old to receive the pneumococcal vaccine (PCV7).

93. Systematic Review on Nonopioid Pharmacologic Treatments for Chronic Pain: Surveillance Report 3 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-3-nonopioid-pharm-chronic-pain.pdf
    July 01, 2022 - ), intermediate-term treatment duration (6 to <12 months), and long- term treatment duration (≥12 months … ), intermediate-term treatment duration (6 to <12 months), and long-term treatment duration (≥12 months … ), intermediate term (6 to <12 months), and long-term (≥12 months) followup. … ), intermediate-term treatment duration (6 to <12 months), and long-term treatment duration (≥12 months … 12 months), and long-term treatment duration (≥12 months) • We will assess available literature to

94. Renal-Artery-Stenosis Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_surveillance.pdf
    June 01, 2012 - compared to renal artery angioplasty with stent placement on long-term clinical outcomes (at least 6 months … [sample size =55] The survival curves were nearly identical for the two groups over 42 months. … , 95% CI= 55, 100 Patients without stent: 79 months, 95% CI= 68, 90 Mean survival for stented patients … Medical Treatment (dose:NR ; n= 22) Mean follow up 15 months improveme nts in hypertensio n … (range 35–89 months) BP Control, Renal function Medical vs.

95. Rapid Evidence Product: No-Touch Modalities for Disinfecting Patient Rooms in Acute Care Settings (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-review-no-touch-modalities.pdf
    May 01, 2022 - The study did not explicitly report what methods were used for cleaning in the prior 12 months. … Compared with the prior 12 months, there was a 44 percent unadjusted reduction on overall incidence … Over 20 months (704 admissions), no change in CDI was identified: trend incidence rate ratio (IRR): … April 2015 to November 2016, 20 months Standard cleaning* + Pulsed Xenon (PX)-UV vs. … Acute care non-ICU hospital beds at a community hospital 25.5 months, including 3.5 months

96. Rapid Evidence Product_Nonemergent Percutaneous Coronary Intervention Versus Optimal Medical Treatment for Stable Ischemic Heart Disease: A Rapid Response Literature Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/rapid-evidence-heart-disease.pdf
    October 01, 2022 - (mean range, 1.5 to 60 months). … Over a median follow-up period of 41 months (interquartile range, 28 to 60 months), the addition of … OMT alone Follow-up: Mean range: 1.5 to 60 months; Mean: 27.7 months All-cause mortality (11): … : 1.8 vs. 3.4 12 months: 2.0 vs. 1.1 KCCQ overall summary score: 6 months: MD 6.5 (95% CI 3.5–9.5 … ) 12 months: MD 4.5 (95% CI 1.4–7.7) 24 months: MD 2.6 (95% CI -0.7–5.8) Serious Adverse Event,

97. Observed Association Between Antidepressant Use and Pneumonia Risk Was Confounded by Comorbidity Measures (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/antidepressants-seniors-pneumonia_research.pdf
    May 01, 2008 - We required at least six months of data prior to study eligibility to ensure an adequate period in which … for non-depression diagnoses in the prior thirty days, number of hospitalizations in the prior six months … The incidence of pneumonia is expected to peak during the winter months and decline during the summer … (average 2.8 vs. 0.8), hospital visits over the prior six months (mean 0.72 vs. 0.13), and number of … ‡ Adjusted for age, sex, calendar year, number of non-depression GP visits in the prior six months,

98. Management of Insomnia Disorder in Adults: Current State of the Evidence (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/insomnia_clinician.pdf
    August 01, 2017 - opportunity for sleep, and are experienced on a chronic basis (at least 3 nights per week for at least 3 months … Effectiveness was demonstrated across modes of delivery and was sustained in the long term (at least 6 months … suvorexant) improved some outcomes among the general adult population in primarily short-term (up to 3 months … Pharmacological Therapy: Adverse Effects (See Table 3) �� Evidence regarding the long-term (more than 3 months … outcomes (���) May improve (���) May improve some outcomes (���) CBT-I (studies lasting ≥ 6 months

99. Treatments for Schizophrenia in Adults: A Systematic (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/executive-summary-2017-schizophrenia-adult.pdf
    January 01, 2017 - being delusions, hallucinations, or disorganized speech, and the presence of symptoms for at least 6 months … ; not during 6 to 12 months of treatment • Early team-based multi-component treatment programs for … treatment; difference not found with longer followup versus usual care (up to 18 months followup) … rates than usual care from 7 to 12 months • Family interventions: Lower than usual care 0 to 6 months … , 13 to 24 months, 5 years; not different from usual care at 25 to 36 months • Illness self-management

100. Patient-Monitoring-Systems-Appendix-C (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/patient-monitoring-systems-appendix-c.xlsx
     January 01, 2024 - 2019 to April 2021 Australia Pre-post NR 1 Both 28639 General wards NR NR Bucknall, 2022 No NR 12 months … SD NR) NR NR None Weller, 2018 Arm 1 -Usual care/In person Control Hospital length of stay, days 5 months … NS NR None Weller, 2018 Arm 2 Intervention (continuous monitoring) Hospital length of stay, days 5 months … None Weller, 2018 Arm 2 Intervention (continuous monitoring) ICU transfers, per 1000 discharges 5 months … ) NR NR None Miles, 2023 Arm 1 -Usual care/In person Pre-intervention In-hospital cardiac arrest 7 months